<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://med-rise.com/medical-news/semaglutide-children-6-to-11-step-young-nejm</loc><news:news><news:publication><news:name>MedRise</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T07:37:24.977000-06:00</news:publication_date><news:title>Semaglutide Cut BMI 13.5% in Children Ages 6 to 11 in the Phase 3 STEP Young Trial</news:title></news:news></url><url><loc>https://med-rise.com/medical-news/fda-approves-cemdisiran-livsayis-myasthenia-gravis-sirna</loc><news:news><news:publication><news:name>MedRise</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T07:32:22.373000-06:00</news:publication_date><news:title>FDA Approves Cemdisiran, the First siRNA Drug for Myasthenia Gravis, Given Every 3 Months</news:title></news:news></url></urlset>
